Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators

Ítems similars

• Implantable cardioverter defibrillator: Charge saver, not syncope saver!
  per: Chemello, Diego, et al.
  Publicat: (2010)
• Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study
  per: Parkash, Ratika, et al.
  Publicat: (2004)
• Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: What are the risks of waiting?
  per: Ghosh, Nina, et al.
  Publicat: (2009)
• Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population‐Based Registry
  per: Almehmadi, Fahad, et al.
  Publicat: (2017)
• Heart rate in patients with reduced ejection fraction: relationship between single time point measurement and mean heart rate on prolonged implantable cardioverter defibrillator monitoring
  per: Habal, Marlena V., et al.
  Publicat: (2018)